ResearcherIrmandade da Santa Casa de Misericórdia de São PauloNo recent work listed

Tércio De Campos

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3927-4530; OpenAlex author ID A5024402599. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2017: 2 papers

Papers 2

Angiolymphatic invasion as a prognostic fator in resected N0 pancreatic adenocarcinoma. Last author DOI 10.1590/0102-6720201700010012 ↗
TWELVE YEARS OF EXPERIENCE USING CHOLECYSTOJEJUNAL BY-PASS FOR PALLIATIVE TREATMENT OF ADVANCED PANCREATIC CANCER. Last author DOI 10.1590/0102-6720201700030009 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ricardo Vitor Silva de Almeida · 1 shared paper, 2017 · strength 0.09
- Paper Angiolymphatic invasion as a prognostic fator in resected N0 pancreatic adenocarcinoma. DOI 10.1590/0102-6720201700010012 ↗
Marcos Belotto de Oliveira · 1 shared paper, 2017 · strength 0.08
- Paper TWELVE YEARS OF EXPERIENCE USING CHOLECYSTOJEJUNAL BY-PASS FOR PALLIATIVE TREATMENT OF ADVANCED PANCREATIC CANCER. DOI 10.1590/0102-6720201700030009 ↗
Renata D’Alpino Peixoto · 1 shared paper, 2017 · strength 0.08
- Paper TWELVE YEARS OF EXPERIENCE USING CHOLECYSTOJEJUNAL BY-PASS FOR PALLIATIVE TREATMENT OF ADVANCED PANCREATIC CANCER. DOI 10.1590/0102-6720201700030009 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.